SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use

This publication has 16 references indexed in Scilit:

• The optimum time for irradiation relative to tumour concentration of hypoxic cell sensitizers
  The British Journal of Radiology, 1980
• A drug for improved radiosensitization in radiotherapy
  British Journal of Cancer, 1980
• Is tumour radiosensitization by misonidazole a general phenomenon?
  British Journal of Cancer, 1980
• Misonidazole neurotoxicity in the mouse: Evaluation of functional, pharmacokinetic, electrophysiologic and morphologic parameters
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1978
• Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple doses
  British Journal of Cancer, 1977
• Clinical Phase I Study of the Hypoxic Cell Radiosensitizer RO-07-0582, A 2-Nitroimidazole Derivative
  Radiology, 1977
• A New Substituent Constant, π, Derived from Partition Coefficients
  Journal of the American Chemical Society, 1964
• A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.
  Journal of the American Pharmaceutical Association (Scientific ed.), 1957